Status:
COMPLETED
Evaluation of SVV From NICOM as a Predictor of Fluid Responsiveness in Prone Position During Spine Surgery
Lead Sponsor:
Samsung Medical Center
Conditions:
Fluid Responsiveness
Prone Position
Eligibility:
All Genders
20-80 years
Brief Summary
NICOM® is a recently developed noninvasive cardiac output monitoring device, and indices derived from NICOM® such as SVV has been reported to predict fluid responsiveness in the previous studies. Howe...
Eligibility Criteria
Inclusion
- ASA I or II patients undergoing spine surgery in prone position
Exclusion
- Pre-existing arrhythmic disorders/moderate to severe valvular heart disease/obstructive pulmonary disease (COPD grade \>2), left ventricular dysfunction with LV EF less than 50, preoperative need for inotropics or vasopressors
- BMI \>30kg/m\^2 or \<15kg/m\^2
- Preoperative serum Cr \> 1.3mg/dL
- Patients with coagulopathy
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02277353
Start Date
October 1 2014
End Date
June 1 2015
Last Update
July 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Seoul Hospital, Samsung Medical Center
Seoul, South Korea, 135-710